Perspective: Tumour spread - The problems of latency

Journal of Pathology

Volumn 187, Issue 1, 1999, Pages 91-94

  Hart, Ian R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Angiostatin; Apoptosis; Dormancy; Endostatin; Latency; Proteases

Indexed keywords

ANGIOSTATIN; ENDOSTATIN; PROTEINASE;

ANGIOGENESIS; LATENT PERIOD; METASTASIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

ANIMALS; CELL DIVISION; HUMANS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0032961067     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199901)187:1<91::AID-PATH234>3.0.CO;2-J     Document Type: Review

References (27)

1. Woodruff M. Interaction of cancer and host (the Walter Hubert Lecture, 1982). Br J Cancer 1982; 46: 313-322.
2. Callaway MP, Briggs JC. The incidence of later recurrence (greater than 10 years): an analysis of 536 consecutive cases of cutaneous melanoma. Br J Plast Surg 1989, 42: 46-49.
3. Fidler IJ, Gersten DM, Hart IR. The biology of cancer invasion and metastatis. Adv Cancer Res 1978; 28: 149-250.
4. Eccles SA, Alexander P. Immunologically-mediated restraint of latent tumour metastases. Nature 1975; 257: 52-53.
5. Wheelock EF, Weinhold KJ, Levich J. The tumor dormant state. Adv Cancer Res 1981; 34: 107-140.
6. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328.
7. Harris AL. Antiangiogenesis for cancer therapy. Lancet 1997; 349: 13-15.
8. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1989; 82: 4-6.
9. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65-71.
10. O'Reilly M, Rosenthal R, Sage EH, et al. The suppression of tumor metastases by a primary tumor. Surg Forum 1993; 44: 474-476.
11. Gately S, Twardowski P, Stack MS, et al. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor angiostatin. Cancer Res 1996; 56: 4887-4890.
12. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89: 1260-1270.
13. O'Reilly MS, Boehm T, Shiong Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
14. Liotta L, Steeg P, Stetler-Stevenson W. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-336.
15. Sage EH. Pieces of 8 - bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol 1997; 7: 182-186.
16. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390: 404-407.
17. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 1996; 2: 689-692.
18. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1995; 1: 149-153.
19. Cao Y, O'Reilly MS, Marshall B, Flynn E, Ji R-W, Folkman J. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J Clin Invest 1998; 101: 1055-1063.
20. Dong Z, Kumar R, Yang X, Fidler I. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997; 88: 801-810.
21. Sato TN. A new approach to righting cancer? Proc Natl Acad Sct USA 1998; 95: 5843-5844.
22. Griscelli F, Li H, Bennaceur-Griscelli A, et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitotis arrest. Proc Natl Acad Sci USA 1998; 95: 6367-6372.
23. Yu W, Kim J, Ossowski L. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy. J Cell Biol 1997; 137: 767-777.
24. Uhr JW, Scheuermann RH, Street NE, Vitetta EH. Cancer dormancy: opportunities for new therapeutic approaches. Nature Med 1997; 3: 505-509.
25. Fisher B, Fisher ER. Experimental evidence in support of the dormant tumor cell. Science 1959; 130: 918-920.
26. Schwenk TL. Cancer and depression. Primary Care 1998; 25: 505-512.
27. Schiffenbauer YS, Abramovitch R, Meir G, et al. Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 1997; 94: 13203-13208.